Moreover, reduced TSHZ2 expression in BC cells promotes breast tumorigenesis through the activation of GLI1, which aligns with our findings that TSHZ2 can inactivate the Hedgehog‐GLI signaling pathway, thereby reducing DCIS cell proliferation and metastasis. Here, TSHZ2 is linked to ductal breast carcinoma in situ.